Optimizing ovarian stimulation for IVF using GnRH antagonists;Optimiser la stimulation ovarienne en FIV grâce aux antagonistes de la GnRH

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 33, Issue 6 II, 2004, Pages

  Kolibianakis, E M ^a,b  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b IFREARES Bordeaux Aquitaine Sante ^*  (France)

Author keywords

GnRH antagonists; LH; Ovarian stimulation; Prolongation of follicular phase

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; PROGESTERONE; STEROID RECEPTOR;

EMBRYO; ENDOMETRIUM; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; OOCYTE; OVULATION INDUCTION; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; REVIEW;

ANOVULATION; CLINICAL PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; ENDOMETRIUM; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY RATE; TIME FACTORS;

EID: 5644295550     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Wikland M, Bergh C, Borg K, Hillensjo T, Howles CM, Knutsson A, Nilsson L, Wood M. A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI. Hum Reprod 2001; 16: 1676-81.
2. Aboulghar MA, Mansour RT, Serour GI, Al-Inany HG, Amin YM, Aboulghar MM. Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration: randomized controlled trial. Reprod Biomed Online 2004; 8: 524-7.
3. Kol S, Lightman A, Hillensjo T, Devroey P, Fauser B, Tarlatzis B, Mannaerts B, Itskovitz-Eldor J. High doses of gonadotrophin-releasing hormone antagonist in in vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. Hum Reprod 1999; 14: 2242-4.
4. Kolibianakis EM, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A, Devroey P. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril 2002; 78: 1025-9.
5. Ludwig M, Katalinic A, Banz C, Schroder AK, Loning M, Weiss JM, Diedrich K. Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study. Hum Reprod 2002; 17: 2842-5.
6. Mochtar MH. The effect of an individualized GnRH antagonist protocol on folliculogenesis in IVF/ICSI. Hum Reprod 2004; 19: 1713-8.
7. Escudero E, Bosch E, Crespo J, Simon C, Remohi J, Pellicer. A comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients. Fertil Steril 2004; 81: 562-6.
8. Kolibianakis EM, Albano C, Kahn J, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril 2003; 79: 873-80.
9. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 2004; 82: 102-7.
10. Borm G, Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 2000; 15: 1490-8. Erratum in: Hum Reprod 2000; 15: 1877.
11. Borm G, Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 2000; 15: 1490-8. Erratum in: Hum Reprod 2000; 15: 1877.
12. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles. J Clin Endocrinol Metab 2003; 88: 5632-7.
13. Kolibianakis EM, Zikopoulos K, Smitz J, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists. Hum Reprod 2004; May 20 [Epub ahead of print].